🇺🇸 FDA

Drug profile · INN

tretinoin

TRETINOIN

approved
US status
approved
Patents linked
4
News articles
0

Quick answer

tretinoin (TRETINOIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN tretinoin
Brand TRETINOIN
Route TOPICAL
Formulation CAPSULE
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 12005123

    Conjugate of isotretinoin and peptide

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11351266

    Conjugate of isotretinoin and peptide

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9982259

    Transthyretin allele selective UNA oligomers for gene silencing

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 6080386

    Suspended ultra-sound induced microbubble cavitation imaging

    Expires Mon Jun 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is tretinoin?

tretinoin (TRETINOIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for tretinoin?

TRETINOIN is a marketed brand name for tretinoin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of tretinoin?

tretinoin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.